Business & Regulation
Thermo Fisher completes $912.5m acquisition of CorEvitas
Thermo Fisher completes the acquisition of CorEvitas following a drop in Q2 2023 revenues compared to 2022.
The UK government’s road to creating a ‘science superpower’
ArchiMed acquires neurodiagnostic devices provider Natus Medical
Magazine: A choppy history of racial bias in oximetry
Medtronic’s revenue increases 5% to $31.69bn in FY22
FDA identifies Avanos Medical’s Cortrak* 2 EAS recall as Class I
